Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.02.526846Source: DataRank Database

Quercetin selectively reduces expanded repeat RNA levels in models of myotonic dystrophy is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)OA: greenTopics (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Sawyer M Hicks ORCID,Jesús Frías ORCID,Sweta Vangaveti ORCID,Masayuki Nakamori ORCID,John D. Cleary ORCID

Live enrichment

PubMed:36778282 OpenAlex:https://openalex.org/W4319162149

National Institutes of Health

Grant: 1R01NS104010-01A1

Identifying the RNA Splicing and Gene Expression Changes that cause Congenital Myotonic Dystrophy

National Institutes of Health

Grant: 5T32GM132066-05

RNA Science and Technology in Health and Disease

National Institutes of Health

Grant: 2P50NS048843-16

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center

National Institutes of Health

Grant: 3R01NS120485-03S2

Design, Synthesis and Efficacy of New Small Molecule Therapeutics to Impede Myotonic Dystrophy

NINDS NIH HHS

Grant: P50 NS048843

NINDS NIH HHS

Grant: R01 NS104010

NINDS NIH HHS

Grant: R01 NS120485

NIGMS NIH HHS

Grant: T32 GM132066

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/02/02/2023.02.02.526846.full.pdf

GREENhttps://www.biorxiv.org/content/biorxiv/early/2023/02/02/2023.02.02.526846.full.pdf

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/02/02/2023.02.02.526846.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.02.02.526846

repositoryhttps://doi.org/10.1101/2023.02.02.526846

Fields of Study

Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyMuscle Physiology and DisordersMedicineBiology0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Myotonic dystrophyRNA splicingRNABiologyAlternative splicingTrinucleotide repeat expansionExonTransgeneQuercetinTranscription (linguistics)GeneticsCell biologyCancer researchGeneBiochemistryAlleleArticle

Sustainable Development Goals

SDG 0: Good health and well-being